Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SNDX | Syndax Pharmaceuticals Inc | President, Head of R&D | $2.42M | Feb 7, 2024 | ||
ZYME | Zymeworks Inc. | Director | Dec 10, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|